Manufacturing

The maturation of artificial intelligence in the life sciences is now being judged by its ability to facilitate commercial execution rather than just generating digital designs. The recent acquisition of the American biotechnology firm Genomatica by Copenhagen-based Again signals a tectonic shift

Identifying CD31 protein expression in engineered tissue constructs serves as a vital indicator that a functional internal blood vessel network has begun to take shape. For patients grappling with catastrophic bone injuries or the aftermath of tumor removals, the quest for a permanent solution

The persistent search for a definitive treatment for Duchenne muscular dystrophy (DMD) has entered a sophisticated new era where regenerative medicine takes center stage against genetic muscle wasting. The FDA has recently cleared an expansion for a Phase 2 clinical trial that evaluates the safety

Improving the safety and efficacy of new medical treatments requires a shift toward research tools that are grounded in human biology and actual patient cell responses. The traditional paradigm of pharmaceutical development has long relied on animal models, which frequently fail to predict human

The clinical success of individualized immunotherapy depends on a high-speed logistical pipeline that must sequence a tumor’s genome and manufacture a bespoke vaccine before a patient relapses. This daunting challenge is particularly acute in the realm of head and neck squamous cell carcinoma, a

Before undergoing advanced cell therapy, Martha Durden-Scroggins experienced extreme physical fluctuations, oscillating between periods of stability and bouts of debilitating weakness. At seventy-one, her aggressive B-cell lymphoma had reached a critical juncture where conventional interventions no